|
|
Britannia Life Sciences Inc
CSE •
Healthcare •
Biotechnology •
Quote as of 10/30/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeCSE
Market Capitalization11.52 mln
Float98.36 mln
Earnings Date08/27/2025
Key Fundamentals
EPS0.11
P/E0.64
ROE104
RPS0.00
ROIC-11.97
ROA77.17
Interest Cover-66.92
EBITDA, mln13.38
EV / EBITDA-0.20
EV / EBIT-0.20
Revenue, mln0.69
Quote Details
Last
0.07
Change
0 (0%)
Open
0.07
Volume
10,000
Turnover
700
Average Volume
83,800
Financial Ratios
Pre-Tax Profit Margin1,931
Leverage Ratio1.13
Current Ratio5.69
Price / Book0.45
Price / Tangible Book0.46
Debt / Equity0.01
Price / Sales15.00
Financial Strength
Altman Z-Score4.78
Piotroski F-Score
5
/ 9
Beneish M-Score2.86
Price to Intrinsic Value0.75
Price to Graham Number0.67
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
7.69% |
85
/ 100
 |
| 1 Month |
0% |
84
/ 100
 |
| 2 Months |
-22.22% |
52
/ 100
 |
| 6 Months |
-30% |
59
/ 100
 |
| 1 Year |
0% |
71
/ 100
 |
|
| |
